相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers
SeungHwan Lee et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Human Tissue Distribution of Voriconazole
Stefan Weiler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
Peter F. Troke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients
Kelong Han et al.
CLINICAL PHARMACOKINETICS (2011)
Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients
Kelong Han et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
John W. Baddley et al.
CLINICAL INFECTIOUS DISEASES (2010)
Voriconazole concentrations and outcome of invasive fungal infections
S. Miyakis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia
Antonio Torres et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Livio Pagano et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
Catherine Cordonnier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Clinician Ordering Practices for Voriconazole Therapeutic Drug Monitoring: Experiences of a Referral Laboratory
Spiros Miyakis et al.
THERAPEUTIC DRUG MONITORING (2010)
Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation
Steven M. Trifilio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
Koki Ueda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Voriconazole plasma monitoring
A. C. Pasqualotto et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria
Brahm H. Segal et al.
CLINICAL INFECTIOUS DISEASES (2008)
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function
F. Alvarez-Lerma et al.
JOURNAL OF CHEMOTHERAPY (2008)
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
Steve Trifilio et al.
CANCER (2007)
Voriconazole - A review of its use in the management of invasive fungal infections
Lesley J. Scott et al.
DRUGS (2007)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacokinetic/pharmacodynamic profile of voriconazole
Ursula Theuretzbacher et al.
CLINICAL PHARMACOKINETICS (2006)
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients
I Mohammedi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
S Trifilio et al.
BONE MARROW TRANSPLANTATION (2005)
Oral versus intravenous therapy in the treatment of systemic mycosis
JRA Perea et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Development and validation of a high-performance liquid chromatography assay for voriconazole
GJ Pennick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Effect of omeprazole on the steady-state pharmacokinetics of voriconazole
N Wood et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
L Purkins et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
